Mr. Roeseler joins Rezolute with over 20 years of commercial leadership experience in the pharmaceutical and biotechnology industry including building commercial teams in support of rare disease launches, product and lifecycle management, brand strategy and payer marketing. 

Prior to joining Rezolute, Jeff was the founder of Biocentric, LLC, where he provided strategic advice to clinical stage rare disease companies as they advanced their portfolios towards commercialization. Earlier in his career Jeff was the head of global marketing at Insmed where he led the development and global commercialization of a novel first-in-class therapy for a rare, life- threatening respiratory disease. From 2001- 2013 Jeff held various management roles of increasing responsibility across the commercial organization of Shire. During his tenure, he supported the launch of multiple blockbuster medicines and the integration of the Advanced Bio Healing acquisition. 

Jeff received his B. A. and M.B.A from Regis University in Denver, CO.